These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14566257)

  • 1. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Ectors N; Fieuws S; Moons J; Nafteux P; Van Raemdonck D;
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1121-8. PubMed ID: 14566257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; de Boer DJ; Busch OR; Obertop H; van Lanschot JJ
    Am J Surg Pathol; 2006 Feb; 30(2):171-6. PubMed ID: 16434890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.
    Nafteux PR; Lerut AM; Moons J; Hölscher AH; Bollschweiler E; van Berge Henegouwen MI; Lagarde SM; van Lanschot JJ; Messager M; Mariette C; D'Journo XB; Thomas PA; De Leyn PR
    Ann Surg; 2015 Nov; 262(5):809-15; discussion 815-6. PubMed ID: 26583670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
    Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
    Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
    Schomas DA; Quevedo JF; Donahue JM; Nichols FC; Romero Y; Miller RC
    Dis Esophagus; 2010 Apr; 23(3):232-9. PubMed ID: 19515184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer.
    D'Journo XB; Avaro JP; Michelet P; Trousse D; Tasei AM; Dahan L; Doddoli C; Guidicelli R; Fuentes P; Seitz JF; Thomas P
    J Thorac Oncol; 2009 Apr; 4(4):534-9. PubMed ID: 19347985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.
    Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI
    Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.
    Depypere LP; Moons J; Mariette C; D'Journo XB; Thomas PA; Hölscher AH; Bollschweiler E; van Berge-Henegouwen MI; Van Lanschot JJB; Lerut TEMR; Nafteux PR
    Ann Surg; 2018 Dec; 268(6):1000-1007. PubMed ID: 28742714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction.
    Saha S; Dehn TC
    Dis Esophagus; 2001; 14(1):32-6. PubMed ID: 11422303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
    van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System.
    D'Annoville T; D'Journo XB; Loundou A; Trousse D; Dahan L; Doddoli C; Seitz JF; Thomas PA
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e207-11; discussion e211. PubMed ID: 23818566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
    Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
    Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy.
    Lagarde SM; Navidi M; Gisbertz SS; van Laarhoven HW; Sumpter K; Meijer SL; Disep B; Immanuel A; Griffin SM; van Berge Henegouwen MI
    Br J Surg; 2016 Nov; 103(12):1658-1664. PubMed ID: 27696382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
    Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
    Liu JF; Jiang T; Shi ZH; Liu XB
    ANZ J Surg; 2018 Mar; 88(3):218-222. PubMed ID: 27444989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.